ChargePoint (NYSE:CHPT – Free Report) had its target price cut by UBS Group from $1.80 to $1.50 in a research report report published on Tuesday morning, Benzinga reports. They currently have a neutral rating on the stock. Several other analysts also recently weighed in on the company. JPMorgan Chase & Co. downgraded ChargePoint from an […]

StockNews.com upgraded shares of Esperion Therapeutics (NASDAQ:ESPR – Free Report) from a hold rating to a buy rating in a research note released on Tuesday. A number of other brokerages have also recently issued reports on ESPR. Bank of America cut Esperion Therapeutics from a “neutral” rating to an “underperform” rating and dropped their price […]

Cantor Fitzgerald reaffirmed their overweight rating on shares of Disc Medicine (NASDAQ:IRON – Free Report) in a research report report published on Tuesday, Benzinga reports. Cantor Fitzgerald currently has a $85.00 price target on the stock. IRON has been the subject of several other research reports. HC Wainwright restated a “buy” rating and issued a […]

StockNews.com upgraded shares of Syros Pharmaceuticals (NASDAQ:SYRS – Free Report) from a sell rating to a hold rating in a research report sent to investors on Tuesday. SYRS has been the topic of several other research reports. HC Wainwright cut their price objective on Syros Pharmaceuticals from $15.00 to $6.00 and set a “buy” rating […]

Illumina (NASDAQ:ILMN – Get Free Report) was upgraded by stock analysts at Hsbc Global Res from a “hold” rating to a “strong-buy” rating in a research note issued to investors on Thursday, Zacks.com reports. Other equities analysts have also recently issued reports about the stock. StockNews.com started coverage on shares of Illumina in a research […]

Nexstar Media Group (NASDAQ:NXST – Free Report) had its price target trimmed by Benchmark from $225.00 to $215.00 in a research note issued to investors on Monday, Benzinga reports. They currently have a buy rating on the stock. NXST has been the topic of several other research reports. StockNews.com lowered shares of Nexstar Media Group […]

ChargePoint (NYSE:CHPT – Free Report) had its price target reduced by UBS Group from $1.80 to $1.50 in a report issued on Tuesday morning, Benzinga reports. UBS Group currently has a neutral rating on the stock. Other analysts have also issued reports about the company. Royal Bank of Canada lowered their price objective on ChargePoint […]

ASML (NASDAQ:ASML – Free Report) had its price objective trimmed by Wells Fargo & Company from $1,000.00 to $790.00 in a research report sent to investors on Thursday, Benzinga reports. The firm currently has an overweight rating on the semiconductor company’s stock. Other analysts have also recently issued research reports about the stock. Berenberg Bank […]

Nextracker (NASDAQ:NXT – Get Free Report) had its price objective lowered by analysts at Susquehanna from $59.00 to $50.00 in a report released on Wednesday, Benzinga reports. The firm presently has a “positive” rating on the stock. Susquehanna’s price target would suggest a potential upside of 48.94% from the stock’s current price. Several other research […]

UBS Group downgraded shares of Basf (OTCMKTS:BASFY – Free Report) from a buy rating to a neutral rating in a research report sent to investors on Monday, Marketbeat.com reports. Other equities research analysts have also recently issued reports about the company. Citigroup upgraded Basf to a “hold” rating in a report on Wednesday, October 9th. […]

Bank of America reissued their hold rating on shares of ProFrac (NASDAQ:ACDC – Free Report) in a research note published on Monday, Stock Target Advisor reports. The firm currently has a $7.50 price target on the stock. Several other analysts have also recently issued reports on the company. Piper Sandler cut their target price on […]

Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price target boosted by Bank of America from $307.00 to $314.00 in a research report sent to investors on Monday, Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. ALNY has been the topic of a number of other research reports. TD Cowen […]

DA Davidson reiterated their neutral rating on shares of Appian (NASDAQ:APPN – Free Report) in a research note published on Monday morning, Benzinga reports. They currently have a $33.00 target price on the stock. APPN has been the topic of a number of other reports. Barclays lowered their price target on Appian from $32.00 to […]

Arrowhead Pharmaceuticals (NASDAQ:ARWR – Get Free Report) was upgraded by equities research analysts at StockNews.com to a “sell” rating in a research report issued on Thursday. Other analysts have also issued reports about the stock. HC Wainwright reiterated a “buy” rating and issued a $60.00 price target on shares of Arrowhead Pharmaceuticals in a research […]

Fortinet (NASDAQ:FTNT – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “buy” rating to a “hold” rating in a report issued on Thursday. Several other equities analysts have also recently commented on the stock. Morgan Stanley cut their target price on shares of Fortinet from $73.00 to $69.00 and set […]